Cytoplasmic and nuclear Survivin expression in healthy gastric mucosae of equids: A comparative study between horses, donkeys, and mules.

J Equine Vet Sci

Equine Medicine and Surgery Research Line (LIMCE), CENTAURO Research Group, School of Veterinary Medicine, Faculty of Agricultural Sciences, University of Antioquia, Medellin 050010, Colombia.

Published: October 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: Information regarding Survivin protein expression in the gastric mucosa of equids is scarce. This protein has been associated with functions related to modulating apoptosis and promoting mitosis in epithelial cells and is considered part of gastric cytoprotection mechanisms in humans and mice, maintaining mucosal integrity and regulating cellular renewal.

Aims/objectives: This study aimed to determine the expression of cytoplasmic and nuclear Survivin in gastric mucosae of equids (horses, donkeys, and mules).

Methods: A total of 30 healthy stomachs, 10 from each species, were evaluated using histology and immunohistochemistry techniques. Survivin protein was detected with antibody EP119 and with the polymer method.

Results: Immunohistochemistry revealed survivin expression in the gastric mucosa of equids. In horses and mules, the survivin index was evident in the cytoplasm of both glandular (59 ± 55; 55 ± 40) and squamous (15 ± 16; 18 ± 19) mucosa, being significantly higher in the glandular mucosa (P = 0.001; P = 0.041), respectively. In contrast, donkeys showed a higher survivin index in the cytoplasm, but no significant difference was observed between the two types of mucosa (P = 0.506).

Conclusion: Survivin expression in the healthy gastric tissue of equids was localized to the lamina propria and the basal layer of the epithelial layer, predominantly within the cytoplasmic compartment of the cells. However, further techniques are needed to study this protein in Equine Gastric Ulcer Syndrome (EGUS) to assess its potential role in cytoprotection and gastro-adaptation in these species.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jevs.2025.105678DOI Listing

Publication Analysis

Top Keywords

survivin expression
12
cytoplasmic nuclear
8
survivin
8
nuclear survivin
8
expression healthy
8
healthy gastric
8
gastric mucosae
8
mucosae equids
8
horses donkeys
8
survivin protein
8

Similar Publications

Survivin, an inhibitor of apoptosis protein, is minimally expressed in normal adult tissues but overexpressed in multiple cancers. This study investigates survivin expression alongside autophagy markers ATG7 and LC3B in seven solid tumor types in Indian patient samples. Immunohistochemical analysis was performed on 48 cancer tissue samples (breast n = 7, buccal n = 6, cervical n = 5, colon n = 8, renal n = 6, liver n = 10, thyroid n = 6) and adjacent normal tissues (n = 9) using anti-human antibodies against survivin, ATG7, and LC3B.

View Article and Find Full Text PDF

The Hippo pathway and its transcription co-activator YAP play a critical role in the regulation of cell proliferation, apoptosis and the control of organ size. In the past several years, YAP has been found to be expressed in various human cancers, however, its expression in Nasopharyngeal Carcinoma (NPC) remains unstudied. In this report, we found that YAP was overexpressed in human NPC tissues, and its expression was also significantly higher in five NPC cell lines when compared with the nasopharyngeal epithelial cell line NP69 (P < 0.

View Article and Find Full Text PDF

Vitamin D3 reduces the viability of cancer cells in vitro and retard the EAC tumors growth in mice.

PLoS One

September 2025

Center of Excellence in Molecular Biology and Regenerative Medicine (CEMR) Laboratory (DST-FIST supported center, ICMR collaborating center of excellence - ICMR-CCoE), Department of Biochemistry (DST-FIST supported department), JSS Medical College, JSS Academy of Higher Education & Research (JSS AHE

Prior studies from our laboratory have shown that cancer cells exposed to vitamin D3 exhibited reduced proliferation in breast cancer cells due to the upregulation of p53 and downregulation of cyclin-D1. Furthermore, in mice, our group has demonstrated that administration of 125 µg/kg of vitamin D3 retarded the growth of EAC tumors. But, it is unknown whether vitamin D3 exerts similar anti-cancer effects against cell lines representing carcinomas of the liver, colon and rectum, cervix, and brain.

View Article and Find Full Text PDF

Grafting of Resveratrol-Chitosan Nanoparticles as a Promising Radiosensitizer and Protector in DMBA-Induced Breast Cancer in Mice.

Curr Cancer Drug Targets

September 2025

Department of Molecular Biology, Genetic Engineering and Biotechnology Research Institute, University of Sadat City, Sadat City, Menoufia, Egypt.

Introduction: Breast cancer is the most common malignancy among women and the second leading cause of cancer-related deaths worldwide. Resveratrol, a polyphenolic stilbene derivative found in grapes, red wine, and other plants, possesses anti-cancer properties. Various studies have reported the potential of different nanomaterials to act as radiosensitizers against tumor cells.

View Article and Find Full Text PDF

The absence of Peroxiredoxin-1 in human pancreatic ductal adenocarcinoma (PDAC) markedly reduces cell survival and tumor growth when coupled with the inhibition of Ref-1 redox signaling.

Redox Biol

September 2025

Department of Pediatrics and Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN, USA; Indiana University Simon Comprehensive Cancer Center, Indiana University School of Medicine, Indianapolis, IN, USA; Indiana University School of Medicine, Departme

Pancreatic ductal adenocarcinoma (PDAC) remains highly resistant to therapy, surviving despite hypoxia, oxidative stress, and nutrient deprivation. Redox effector factor-1 (Ref-1) regulates several oncogenic transcription factors (TFs) and is controlled by peroxiredoxins (PRDX). We investigated how Ref-1 inhibition by APX2014, combined with PRDX expression, affects pancreatic cancer cells from multiple patient lines.

View Article and Find Full Text PDF